The ELUCID Study: Identifying mechanisms and risk factors for dementia in individuals with late‐onset unexplained epilepsy
The ELUCID Study is a large longitudinal study of LoUE that will define its relationship to Alzheimer's disease and related dementias. Here we describe the study protocol and provide an early report of the baseline demographic and clinical characteristics of the accruing ELUCID study population.
Authors
- Leah J. Blank (ORCID: https://orcid.org/0000-0001-8719-6752)
- Rodrigo Zepeda‐Tello (ORCID: https://orcid.org/0000-0003-4471-5270)
- Mouhsin M. Shafi (ORCID: https://orcid.org/0000-0002-4531-1967)
- Rani A. Sarkis (ORCID: https://orcid.org/0000-0001-8291-7864)
- Aseel Jan
- Tyler E. Gaston (ORCID: https://orcid.org/0000-0002-6525-789X)
- Katie Jung
- Kyle R. Pellerin (ORCID: https://orcid.org/0009-0000-4856-7602)
- Rebecca England Amariglio (ORCID: https://orcid.org/0009-0009-5878-8930)
- Alexis Hankerson
- Maria Camitan (ORCID: https://orcid.org/0009-0001-5247-7025)
- Madeline Taubkin
- Tania Anderson
- Emily Johnson
- ELUCID Study Group
- M. Brandon Westover
- Maddie Leake
- Alice D Lam
Institutions
- Brigham and Women's Hospital (US)
- Beth Israel Deaconess Medical Center (US)
- Harvard University (US)
- University of Alabama at Birmingham (US)
- Massachusetts General Hospital (US)
- The University of Texas Southwestern Medical Center (US)
- Icahn School of Medicine at Mount Sinai (US)
Publication Details
- Journal
- Alzheimer s & Dementia
- Published
- 2025-12-01
- DOI
- https://doi.org/10.1002/alz70856_097236
- Primary Topic
- Epilepsy research and treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00